Rockwell Medical Inc (RMTI) Actualités

Rockwell Medical Announces Third Quarter 2023 Results

Net sales for the third quarter of 2023 were $23.8 million, including concentrates product sales of $21.6 million, both of which were the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Rockwell Medical Names Jesse Neri as Senior Vice President, Finance

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures...

Form 8-K - Current report

Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors

Brings more than 20 years of experience as an entrepreneur scientist, CEO, operator, investor, and board...

Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report